Paper Details

  1. Home
  2. Paper Details

Anastrozole and letrozole: an investigation and comparison of quality of life and tolerability.

Author: DixonJ Michael, DixonOliver M, FallowfieldLesley J, LangridgeCarolyn, MacaskillE Jane, McCaigFiona, McHughMary, MurrayJuliette, RenshawLorna, WilliamsLinda, YoungOliver E

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Anastrozole and letrozole are well-tolerated aromatase inhibitors with similar effects on quality of life.
Paper Details　
Original Abstract of the Article :
Previous studies have demonstrated that both anastrozole and letrozole are well tolerated. Letrozole suppresses estrogen to a greater degree than anastrozole in the serum and breast tumor. Concerns have been raised that greater potency may adversely affect patients' quality of life (QOL). One hundre...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s10549-010-1091-9

データ提供：米国国立医学図書館（NLM）

Anastrozole and Letrozole: A Head-to-Head Comparison for Breast Cancer Treatment

The battle against [breast cancer] is a complex one, with researchers constantly seeking to improve treatment options and minimize side effects. This study examines the effectiveness and tolerability of two commonly used medications, [anastrozole] and [letrozole], both [aromatase inhibitors] used in postmenopausal women with [estrogen receptor-positive breast cancers].

The study, conducted on a group of 181 women, compared the quality of life and tolerability of anastrozole and letrozole. While both medications were well tolerated, the researchers found no significant differences between the two in terms of quality of life or side effects. It's like comparing two types of desert camels, both strong and reliable, each with its unique characteristics but equally capable of navigating the challenges of the journey.

Anastrozole and Letrozole: Equal Effectiveness and Tolerability

The study's findings suggest that both anastrozole and letrozole are effective and well-tolerated treatment options for postmenopausal women with estrogen receptor-positive breast cancers. It's like having two reliable water sources in the desert, each providing essential hydration for those in need.

Personalized Breast Cancer Treatment: Understanding Individual Needs and Preferences

This study underscores the importance of considering individual patient needs and preferences when choosing a treatment option for breast cancer. While both anastrozole and letrozole demonstrated similar effectiveness, patient-specific factors, such as potential side effects and personal preferences, may influence the best choice for each individual.

Dr.Camel's Conclusion

This study offers valuable insights into the comparative effectiveness and tolerability of anastrozole and letrozole for breast cancer treatment. It emphasizes the importance of personalized medicine, considering individual patient needs and preferences to achieve optimal outcomes.

Date :
  1. Date Completed 2011-05-02
  2. Date Revised 2022-03-10
Further Info :

Pubmed ID

20821047

DOI: Digital Object Identifier

10.1007/s10549-010-1091-9

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.